• Mashup Score: 0

    Articles contained in the collection: Global intercompany assessment of icIEF platform comparability for the characterization of therapeutic proteins. (Madren et al.) Two quality and stability indicating imaged cIEF methods for mRNA vaccines. (Krebs et al.) Development of an imaged capillary isoelectric focusing method for characterizing the surface charge of mRNA lipid nanoparticle vaccines….

    Tweet Tweets with this article
    • Interested in #icIEF? 💭 Find out more about this essential technique for the quality control and analytical development of #BioTherapeutics in this free article collection. Learn more ➡️ https://t.co/Ra7xtbqC18 https://t.co/zlrZIUc8bP

  • Mashup Score: 1

    Microbiome, infectious disease, neuroinflammation

    Tweet Tweets with this article
    • OUT NOW✨@SinaiImmunol Specialty Report! CHECK OUT "Turning Bugs into Drugs" featuring @jeremiahfaith1 & Stephanie Tankou. LEARN ABOUT partnerships btwn PrIISM & the Microbiome Translational Center that points to future trtmnt opp w/ live #Biotherapeutics https://t.co/JLxCK2X7RV https://t.co/pTLDhaJdmf

  • Mashup Score: 1
    Online Event - 2 year(s) ago

    Already Registered? Click HereSuccessful development of advanced biotherapeutics relies on extensive characterization and tight quality control of protein interactions. Characterizing the binding properties of complex biomolecules, such as bispecific antibodies or reengineered probiotics, is a critical step. Biophysical data combined with functional assays are needed to predict efficacy and…

    Tweet Tweets with this article
    • LATER TODAY--Don't miss our free webinar "Dualplex Immunoassays Speed the Development of Advanced Biotherapeutics," sponsored by @PerkinElmer There's still time to register today: https://t.co/MvJ398O43i #biotherapeutics #drugddelivery #immunoassays https://t.co/x3CjSbBL2x

  • Mashup Score: 0

    This live clean-room demo shares real-world examples including situational awareness, equipment set up, remote support and documentation.

    Tweet Tweets with this article
    • The next generation of #Manufacturing technology for #BioTherapeutics is here. @ROKAutomation and @Cytiva have combined their #Tech expertise to help #BioPharma companies integrate/advance. Take a look at their real world solutions here: https://t.co/uIb99jPWuK #ROKInfluencer https://t.co/MSiqa0bSqV

  • Mashup Score: 0

    After the successful foureditions of Bioprocessing of Cell therapies, coming up with 5th Annual of Bioprocessing of Biotherapeutics brings together leading bioprocessing scientists to share day-to-day challenges and practical solutions for the development, manufacture and quality of protein expressions, cell, and gene therapies. The virtual event will present detailed…

    Tweet Tweets with this article
    • Join us at our 5th Annual #MarketsandMarkets #Bioprocessing of #Biotherapeutics-UK, EU & APAC- on 20-21 May 2021. Share day-to-day challenges and practical solutions for the development, manufacture and quality of cell and #genetherapies. https://t.co/XzzbBZ3apW

  • Mashup Score: 0

    A number of biosimilar drugs are poised to enter the ophthalmic market. Familiarity with these emerging medications can prepare you to know what to look for when evaluating their use.

    Tweet Tweets with this article
    • In theory, #biosimilars will be comparable to proven #biotherapeutics with regard to safety and efficacy—but available at a lower cost. Will this promise be fulfilled? EyeNet’s cover story examines the pros and cons of these agents. [Academy Members] https://t.co/ohoygaXX1g